{
  "ptid_time": "027_S_4962_2012-10-05",
  "img_path": "/data/qiuhui/data/adni/images/027_S_4962/2012-10-05/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 42,590 mm³, 15.2% above the reference mean. With a Z-score of 0.41 (65.9th percentile), this represents normal volume ; hippocampal volume measures 5,316 mm³, 18.2% below the reference mean. With a Z-score of -1.45 (7.3th percentile), this represents mild atrophy; whole brain volume measures 928,429 mm³, 0.0% above the reference mean. With a Z-score of 0.00 (50.1th percentile), this represents normal volume ; entorhinal cortex volume measures 2,938 mm³, 15.2% below the reference mean. With a Z-score of -0.82 (20.7th percentile), this represents normal volume ; fusiform gyrus volume measures 15,047 mm³, 6.6% below the reference mean. With a Z-score of -0.50 (31.0th percentile), this represents normal volume ; middle temporal gyrus volume measures 17,804 mm³, 1.2% below the reference mean. With a Z-score of -0.11 (45.6th percentile), this represents normal volume . ",
  "text_data": "Age is 80.1 years. Gender is Female. Education: 18 years. Handedness: Right. Race: White. Medical history: Neurologic; Cardiovascular; Dermatologic-Connective Tissue; Musculoskeletal; Gastrointestinal; Renal-Genitourinary; Allergies or Drug Sensitivities. MMSE: 22.0. MoCA: 20.0. Logical Memory: 2.0. APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.43 SUVR (significant elevated); Amyloid beta: 998.20 pg/mL (normal ); Total tau: 472.00 pg/mL (significant elevated); Phosphorylated tau: 47.15 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient shows mild hippocampal atrophy (Z-score -1.45, 7.3th percentile) and normal volumes in other regions. Biomarkers indicate significant tau pathology (elevated T-tau and P-tau) and amyloid deposition (AV45+), but Aβ is normal. Cognitive scores (MMSE 22, MoCA 20) suggest mild impairment.  \n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer’s pathology given tau/AV45 findings, despite normal Aβ).  \n**Confidence:** **Medium** (biomarkers and imaging support MCI, but normal Aβ is atypical for typical AD progression).",
  "timestamp": "2025-07-26T04:05:09.304711"
}